Mixed Topics
Conference Coverage
SCD, beta-thalassemia: CRISPR-based gene therapy `transformative’
Phase 3 results suggest potential for a “functional cure”; this treatment could become first-ever approved CRISPR gene-editing therapy.
From the Journals
Cardiorespiratory fitness linked to cancer risk, mortality?
“The clinical implications of these findings further emphasize the importance of CRF for possibly reducing cancer incidence and mortality.”
Livin' on the MDedge
Placebo effect can be found in a cup of coffee
Plus: Humble shopping carts become diagnostic tools and dirty dentures become homes for respiratory pathogens.
From the Journals
ESMO helps hematologists assess new cancer drugs
The group’s new study evaluation tool, the ESMO-MCBS:H, is aimed at helping doctors and others determine the benefit of new blood cancer therapies...
Feature
Physician suicide roundtable: 8 important initiatives that can help
We ask, how full is your gas tank? Select 1 to 5 (Empty to Full). If they flag low, they receive a follow-up.
Latest News
Harvard medical school sued over stolen body part scandal
The indictment alleges that from 2018 through August 2022, Harvard morgue manager Cedric Lodge stole dissected portions of donated cadavers,...
Livin' on the MDedge
Low-calorie tastes sweeter with a little salt
Plus: Indiana loses its biggest Butt, and sugarless sweeteners lose the aftertaste.
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
Conference Coverage
CMML: GM-CSF inhibitor lenzilumab shows early promise
The PREACH-M trial has yielded encouraging preliminary results in treating CMML, a rare, “insidious” leukemia that can transform into AML.
From the Journals
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
Conference Coverage
PV: Novel rusfertide shows ‘impressive’ efficacy
The novel synthetic form of liver hormone hepcidin represents a “paradigm shift” in polycythemia vera treatment, allowing patients to avoid the...